Allstate Corporation’s Insmed INSM Stock Holding History

Allstate Corporation’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.91M	Buy	23,888 +8,018	+51%	+$1.23M	0.04%	293
2025 Q4	$2.76M	Buy	+15,870	New	+$2.9M	0.04%	292

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Allstate Corporation's INSM Position: Q1 2026 in Review

Allstate Corporation increased its Insmed (INSM) stake by 51% in Q1 2026, buying an estimated $1.23M and bringing the position to 23,888 shares worth $3.91M. The position accounts for 0.04% of the portfolio, ranked #293.

Allstate Corporation first reported a position in INSM in Q4 2025 and has held it in 2 quarters since. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Allstate Corporation held 23,888 shares of Insmed worth $3.91M as of Q1 2026.
Allstate Corporation bought 8,018 Insmed shares in Q1 2026, an estimated $1.23M.
Insmed made up 0.04% of Allstate Corporation's portfolio in Q1 2026, its #293 holding.
Allstate Corporation first reported a position in Insmed in Q4 2025 and has held it in 2 quarters since.
670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.